Earnings Outlook For The Oncology Institute

The Oncology Institute (NASDAQ:TOI) is gearing up to announce its quarterly earnings on Wednesday, 2025-08-13. Here's a quick overview of what investors should know before the release.

Analysts are estimating that The Oncology Institute will report an earnings per share (EPS) of $-0.14.

The announcement from The Oncology Institute is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Here's a look at The Oncology Institute's past performance and the resulting price change:

Quarter

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

-0.07

0

-0.10

EPS Actual

-0.21

-0.14

-0.18

-0.17

Price Change %

28.000000000000004%

2.0%

-11.0%

-18.0%

Market Performance of The Oncology Institute's Stock

Shares of The Oncology Institute were trading at $4.24 as of August 11. Over the last 52-week period, shares are up 839.87%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analysts' Take on The Oncology Institute

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on The Oncology Institute.

The consensus rating for The Oncology Institute is Buy, derived from 1 analyst ratings. An average one-year price target of $6.0 implies a potential 41.51% upside.

Comparing Ratings with Competitors

This comparison focuses on the analyst ratings and average 1-year price targets of ...